Daidian Tablet 25 mg (Empagliflozin)

Adult dose

The recommended dose of this medication is 10 mg once daily for monotherapy or additional combination therapy with insulin and other glucose-lowering agents. If well tolerated and further blood sugar control is needed, the dose can be increased to 25 mg once daily. When this medication is combined with sulfonylureas or insulin, a dose reduction of these medications may be considered to decrease the risk of hypoglycemia. This medication should be taken

This medication should not be used in certain patients. Patients with allergies to the active ingredient or any component of this medication should not take it. Additionally, it is not indicated for patients with type 1 diabetes or diabetic ketoacidosis. Patients with severely impaired kidney function or end-stage renal disease, as well as those currently undergoing dialysis, should also avoid this medication. It contains lactose, so it should not be given to patients with lactose intolerance or associated genetic disorders. Caution should be exercised in patients with slightly impaired kidney function. If kidney function drops below a certain level, the dose may need to be reduced or the medication discontinued. Moreover, this medication is not effective in patients with end-stage renal disease. Caution is also required in patients with mild to moderate heart failure, and it is not recommended for patients with severe heart failure. When used with insulin or insulin secretagogues, the risk of hypoglycemia may increase, necessitating adjustment of the doses of these medications. While taking this medication, watch for symptoms of hypoglycemia, infections, particularly genital and urinary infections, and ketoacidosis. Low blood pressure or dehydration symptoms due to decreased fluid volume may also occur, especially in elderly or hypotensive patients. Ketoacidosis is a rare yet serious side effect that can occur even if blood sugar is not high; if severe nausea, vomiting, abdominal pain, or difficulty breathing arise during treatment, immediate consultation with medical staff is necessary. There may also be a risk of liver damage, so monitor for symptoms of abnormal liver function. Caution is required when driving or operating machinery, especially for those at risk of hypoglycemia. It is recommended that pregnant or breastfeeding women do not use this medication, and it should be discontinued if pregnancy is confirmed. The safety and efficacy in children have not been established, thus it is not for use in individuals under 18 years old. No specific toxicity has been reported in case of overdose, but if overdose is suspected, inform healthcare providers immediately for appropriate care. Store this medication out of reach of children, and be careful not to transfer it to another container as this could affect its quality.

Serious side effects

Urticaria, severe swelling (edema), abnormal urination (urination difficulty), urticaria, angioedema, ketoacidosis, urosepsis and pyelonephritis, perineal necrosis, severe allergic reactions, severe skin reactions, respiratory issues, liver abnormalities (jaundice), serious neurological symptoms, severe edema or urination abnormalities

Mild side effects

• Hypoglycemia
• vulvovaginal candidiasis
• balanitis
• and other genital infections
• increased urination
• decreased fluid volume
• increased serum lipids
• increased blood creatinine
• decreased glomerular filtration rate
• interstitial nephritis

This medication should be stored in a tightly sealed container to prevent moisture and air exposure, and it is safe to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the effectiveness of the medication over time.

Appearance

Light yellow, double convex, oval film-coated tablet

Package unit

30 tablets/bottle